JUST IN | Sam Bankman-Fried sentenced to 25 years in prison for FTX fraud

Home

homepersonal finance NewsInvestment Guide: Amid COVID crisis, do pharma stocks present opportunities?

Investment Guide: Amid COVID crisis, do pharma stocks present opportunities?

In this episode of Investment Guide, Sailesh Raj Bhan, Dy CIO-Eq Invst at Nippon India MF and Anmol Ganjoo, pharma research analyst at JM Financial Institutional Securities, discuss the opportunity pharma companies presents. Is there more headroom for valuations and which stocks should one buy?

By CNBC-TV18 Apr 28, 2021 6:14:06 PM IST (Updated)

Listen to the Article(6 Minutes)

The COVID-19 pandemic has taught us some harsh lessons, and it has also brought some glaring realities back to the surface and one of them is India's healthcare spend as a percentage of GDP.

India's healthcare expenditure is still below 2.5 percent, not even half the 5 percent level advocated by the World Health Organisation and a far cry from developed countries like the US, which is at 8 percent.

But they say in adversity, also lies opportunity. As India looks to scale up its healthcare infrastructure, pharma stocks have been on a tear.

CurrencyCommodities

Currency	Price	Change	%Change